Research finds that a single dose of LSD can alleviate the symptoms of anxiety in those who do not find relief from other ...

Biopharmaceutical company MindMed has announced the first topline data from a novel Phase 2 trial testing high doses of LSD as a treatment for anxiety. The results indicate one to two LSD sessions can ...

Holding company Blackhawk Growth Corp.BLRZF's subsidiary company MindBio Therapeutics Pty Ltd shared the positive data gathered from its Phase 1 clinical trials microdosing LSD formulation in 80 ...

An incredible, first-of-its-kind trial testing the pain-killing properties of LSD microdoses has delivered the compelling suggestion that tiny, non-psychedelic doses of this infamous drug could serve ...

Share on Pinterest The use of psychedelic drugs such as LSD in mental health treatment is at the forefront of clinical research. Lyuba Burakova/Stocksy Psychedelic compounds have gained increased ...

The average scores decreased by 7 points in the LSD group and nearly 9 points in the placebo group, a difference not statistically significant to claim superiority of one treatment method over the ...

The magical and potent hallucinogen lysergic acid diethylamide (LSD) may have a new, clinically significant medical benefit: getting sleep. A new study, entitled “LSD Increases Sleep Duration the ...

By the end of the six weeks, both the LSD and placebo groups had shown significant reductions in ADHD symptoms. On the primary measure, symptoms improved by an average of 7.1 points in the LSD group ...

Low-dose treatment with lysergic acid diethylamide (LSD) failed to improve symptoms of attention deficit-hyperactivity disorder (ADHD) in adults, a double-blind randomized phase IIa trial showed.

In this randomized study, microdosing LSD was not more effective than placebo in reducing ADHD symptoms in adults. Repeated doses of the low-dose LSD were safe in an outpatient setting.